Gavin Corcoran

Gavin Corcoran has overseen successful drug development across multiple therapeutic areas including neurology and psychiatry. He previously served as Chief Medical Officer at Allergan plc, and previously served as Chief Medical Officer of Actavis. Dr. Corcoran was Executive Vice President for Global Medicines Development at Forest Laboratories prior to the acquisition of Forest Laboratories by Actavis. In addition, Dr. Corcoran served as Head of Late Stage Clinical Development for Inflammation and Immunology at Celgene, and as Chief Scientific Officer and head of R&D at Stiefel Laboratories. Earlier in his career, he held leadership roles in clinical development and regulatory affairs at Amgen, Schering-Plough, and Bayer. He received his M.B.B.Ch. from the University of the Witwatersrand and completed his clinical training in internal medicine and infectious diseases at the University of Texas Health Science Center at San Antonio.